• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析子宫内膜样腺癌中激素状态、血管和细胞增殖的情况。

The analysis of hormonal status and vascular and cell proliferation in endometrioid endometrial adenocarcinomas.

机构信息

Department of Pathology, Department of Urology, University of Medicine and Pharmacy of Craiova, Romania;

出版信息

Rom J Morphol Embryol. 2022 Jan-Mar;63(1):113-120. doi: 10.47162/RJME.63.1.11.

DOI:10.47162/RJME.63.1.11
PMID:36074674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9593126/
Abstract

Endometrioid endometrial carcinomas (EECs) are the most common malignancies of the uterus. Hormonal dependence of EEC, in relation to biomolecular mechanisms involved in tumor progression, such as angiogenesis and cell proliferation, are aspects that can contribute to improving the prognosis of patients. We analyzed the immunoexpression of markers addressed to steroid hormone receptors [estrogen receptor (ER), progesterone receptor (PR)], angiogenesis [cluster of differentiation (CD)105∕endoglin] and cell proliferation (Ki-67) in 50 EECs related to the histopathological prognostic criteria of the lesions. In this study, the ER and PR scores were higher in low grade and early stages EEC, the statistical aspects being variable. The CD105 microvessel density and the Ki-67 proliferation index were superior in high grade and advanced stages EEC, the statistical aspects being significant or at the limit of significance. The ER∕PR and CD105∕Ki-67 immunomarker groups indicated a positive linear intragroup relation and a negative linear intergroup relation, suggesting the presence of synergistic and antagonistic molecular mechanisms of tumor endometrial control that can be used to stratify patients for targeted therapy.

摘要

子宫内膜样腺癌(EEC)是最常见的子宫恶性肿瘤。EEC 对激素的依赖性,以及涉及肿瘤进展的生物分子机制,如血管生成和细胞增殖,是可以改善患者预后的方面。我们分析了 50 例 EEC 中标记物的免疫表达,这些标记物针对甾体激素受体[雌激素受体(ER)、孕激素受体(PR)]、血管生成[分化群(CD)105/内格林]和细胞增殖(Ki-67),这些 EEC 与病变的组织病理学预后标准有关。在这项研究中,低级别和早期 EEC 的 ER 和 PR 评分较高,统计学方面是可变的。高级别和晚期 EEC 的 CD105 微血管密度和 Ki-67 增殖指数较高,统计学方面具有显著意义或接近显著意义。ER/PR 和 CD105/Ki-67 免疫标志物组表明存在正线性组内关系和负线性组间关系,提示存在协同和拮抗的肿瘤子宫内膜控制分子机制,可用于对患者进行靶向治疗分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a51/9593126/d7fd983f8875/RJME-63-1-113-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a51/9593126/3b417f9921e3/RJME-63-1-113-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a51/9593126/edaec3d191f1/RJME-63-1-113-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a51/9593126/589d37e0b70e/RJME-63-1-113-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a51/9593126/d7fd983f8875/RJME-63-1-113-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a51/9593126/3b417f9921e3/RJME-63-1-113-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a51/9593126/edaec3d191f1/RJME-63-1-113-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a51/9593126/589d37e0b70e/RJME-63-1-113-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a51/9593126/d7fd983f8875/RJME-63-1-113-fig4.jpg

相似文献

1
The analysis of hormonal status and vascular and cell proliferation in endometrioid endometrial adenocarcinomas.分析子宫内膜样腺癌中激素状态、血管和细胞增殖的情况。
Rom J Morphol Embryol. 2022 Jan-Mar;63(1):113-120. doi: 10.47162/RJME.63.1.11.
2
Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.子宫内膜透明细胞癌的特征在于p53、Ki-67、雌激素和孕激素受体表达的独特模式。
Hum Pathol. 1998 Jun;29(6):551-8. doi: 10.1016/s0046-8177(98)80002-6.
3
Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.Cdc25B与雌激素受体α(ER-α)的协同表达在低级别子宫内膜样腺癌中很常见,但在高级别子宫内膜样癌和非子宫内膜样癌中并不常见。
Cancer Res. 2003 Oct 1;63(19):6195-9.
4
Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.酷似子宫内膜样腺癌的浆液性子宫内膜癌:一组疑难病例的临床病理及免疫组化研究
Am J Surg Pathol. 2004 Dec;28(12):1568-78. doi: 10.1097/00000478-200412000-00004.
5
Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation.子宫内膜样腺癌以及具有鳞状、黏液性、分泌性和纤毛细胞分化的子宫内膜样腺癌中雌激素和孕激素受体、Ki-67及p53免疫反应性的比较
Hum Pathol. 1998 Sep;29(9):924-31. doi: 10.1016/s0046-8177(98)90197-6.
6
Do estrogen, progesterone, P53 and Ki67 receptor ratios determined from curettage materials in endometrioid-type endometrial carcinoma predict lymph node metastasis?刮宫标本中雌孕激素受体、P53 及 Ki67 受体比值与子宫内膜样型子宫内膜癌淋巴结转移的关系
Curr Probl Cancer. 2020 Feb;44(1):100498. doi: 10.1016/j.currproblcancer.2019.07.003. Epub 2019 Jul 26.
7
Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression.子宫内膜癌:类固醇激素受体表达与低血管生成及bcl-2表达的关联
Virchows Arch. 2001 May;438(5):470-7. doi: 10.1007/s004280000361.
8
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer.EphA2 过表达和血管生成在子宫内膜癌中的临床和生物学影响。
Cancer Biol Ther. 2010 Dec 15;10(12):1306-14. doi: 10.4161/cbt.10.12.13582.
9
[The value of progesterone and estrogen receptors expression in tissue microarray method in prognosis of patients with endometrioid endometrial cancer].组织芯片法检测孕激素和雌激素受体表达在子宫内膜样腺癌患者预后中的价值
Ginekol Pol. 2013 Feb;84(2):95-101. doi: 10.17772/gp/1547.
10
Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.乳铁蛋白在子宫内膜癌中的免疫表达:与性类固醇激素受体(雌激素受体和孕激素受体)、增殖指数(Ki-67和核仁组成区嗜银蛋白)及生存的关系
Oncol Rep. 2006 Aug;16(2):257-63.

本文引用的文献

1
Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer.子宫内膜癌中的雌激素受体、孕激素受体和HER2受体标志物
J Cancer. 2020 Jan 16;11(7):1693-1701. doi: 10.7150/jca.41943. eCollection 2020.
2
Triple negative endometrial cancer: Incidence and prognosis in a monoinstitutional series of 220 patients.三阴性子宫内膜癌:220例单中心病例系列的发病率及预后
Oncol Lett. 2020 Mar;19(3):2522-2526. doi: 10.3892/ol.2020.11329. Epub 2020 Jan 22.
3
Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel.
采用基于十二基因 NGS -panel 的分子方法对子宫内膜癌进行预后分类。
Sci Rep. 2019 Dec 2;9(1):18093. doi: 10.1038/s41598-019-54624-x.
4
Clear cell renal cell carcinomas - epithelial and mesenchymal immunophenotype.
Rom J Morphol Embryol. 2018;59(4):1189-1194.
5
Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma.一组免疫组织化学标志物在子宫内膜癌管理中的潜在作用
J Pathol Transl Med. 2019 May;53(3):164-172. doi: 10.4132/jptm.2019.02.12. Epub 2019 Feb 28.
6
The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.I 级和 II 级子宫内膜样腺癌中雌激素和孕激素受体的预后意义:激素受体在风险分层中的作用。
J Gynecol Oncol. 2019 Jan;30(1):e13. doi: 10.3802/jgo.2019.30.e13. Epub 2018 Oct 29.
7
Molecular Genetics of Endometrial Carcinoma.子宫内膜癌的分子遗传学。
Annu Rev Pathol. 2019 Jan 24;14:339-367. doi: 10.1146/annurev-pathol-020117-043609. Epub 2018 Oct 17.
8
The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer.血管内皮生长因子-A以及基质金属蛋白酶-2和-9对子宫内膜癌血管生成、转移及预后的影响。
Onco Targets Ther. 2017 Sep 19;10:4617-4624. doi: 10.2147/OTT.S132558. eCollection 2017.
9
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
10
Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?1型和2型子宫内膜癌之间雌激素受体或孕激素受体的阳性情况是否不同?
Oncotarget. 2017 Jan 3;8(1):506-511. doi: 10.18632/oncotarget.13471.